drugset / Trial / NCT04994990

Effective OnabotulinumtoxinA Dose Response Study for Upper Facial Wrinkles

NCT04994990

Withdrawn Northwell Health
RandomizedParallel-groupQuadruple-blindOther

Summary

This research is being done to determine if lower doses of botox than what is currently recommended can give similar results to patients, at lower cost and lower risk to them. Subjects will receive botox in the same areas of the upper face with standard doses on one side of the face. On the other side, double the botox concentration will be administered, free of charge to the participant, in order to see if the difference in concentration creates a difference in wrinkle reduction and participant satisfaction over time.

Timeline

Start
2023-05-25
Primary completion
2024-11-30
Completion
2025-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic

Indications

No indication recorded.